Rapid ASPECTS is the First Ever Neuroimaging Solution to Receive CADx Clearance from the FDA
RapidAI™ empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically proven, data-driven technology. With our validated, trusted products developed by medical experts, clinicians worldwide are improving patient care and outcomes every day.
The latest automated tools to improve stroke care. Whether detecting intracranial hemorrhage, early ischemic change, thrombosis location or low ADC values, get reliable results anytime, anywhere.
Initially validated by an NIH-sponsored DEFUSE 2 study published in 2012, and further studied by numerous worldwide trials, RapidAI continues to show evidence of success, ultimately helping healthcare professionals save lives.
“...Rapid is unparalleled in ease of implementation and use. RAPID elevates perfusion imaging in the management of acute ischemic stroke.”
“I’ve always pushed for faster reviewing of images. Now, through RapidAI, we have it.”
“...Rapid...shifts our 'speed to decision' to less than two minutes and is accessible 24/7/365.”